Ken Griffin Nls Pharmaceutics Ltd. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nls Pharmaceutics Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 136,270 shares of NLSP stock, worth $531,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,270
Previous 19,183
610.37%
Holding current value
$531,453
Previous $3,000
866.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NLSP
# of Institutions
10Shares Held
8.53MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$22.4 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.31MShares$9.01 Million0.01% of portfolio
-
Ubs Group Ag236KShares$919,3190.0% of portfolio
-
Jane Street Group, LLC New York, NY43.7KShares$170,3200.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny21.8KShares$84,9300.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $114M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...